The firm sees the new panel as an important step forward in its strategy to further penetrate the molecular diagnostics market with its qPCR products.
Researchers from Protagen, Targos, and elsewhere have identified autoantibody biomarkers specific to patients diagnosed with prostate cancer.
Researchers in Belgium and the UK showed that their custom viral panel on Thermo Fisher's TaqMan qPCR array card is effective in samples from immunocompromised patients.
The product introduction comes about two years after the company merged with AmpliDiag and Genewave.
CEO Lars Kongsbak said that the proceeds will be used to strengthen the company's capital resources and to expand its inventory in light of growing demand for its qPCR arrays, miRcury microRNA microarrays, and other products and services.
Lonza is distributing Bar Harbor BioTechnology's new tools under an exclusive agreement.
360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.
The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.
In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.
Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.